Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about Capricor Therapeutics, Inc. - 2025/12/05
$172.5 Million
Image
Capricor Therapeutics
Confidentially Marketed Follow-On Offering
Left Bookrunner
Read more
about Protara Therapeutics, Inc. - 2025/12/08
$75.0 Million
Image
Protara Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Fennec Pharmaceuticals Inc. - 2025/11/13
$40.2 Million
Image
Fennec Pharmaceuticals
Confidentially Marketed Follow-On Offering
Lead Bookrunner
Read more
about Inventiva Pharma - 2025/11/12
$172.5 Million
Image
Inventiva Pharma
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Nektar Therapeutics - 2025/11/12
$110.0 Million
Image
Nektar Therapeutics
ATM Program Common Stock
Lead Sales Agent
Read more
about Inovio Pharmaceuticals, Inc. -2025/11/11
$28.8 Million
Image
Inovio Pharmaceuticals
Confidentially Marketed Follow-On Offering
Sole Manager
Read more
about Savara Inc. - 2025/10/29
$130.0 Million
Image
Savara
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Praxis Precision Medicines -2025/10/16
$603.8 Million
Image
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Inventiva -2025/10/14
$100.0 Million
Image
Inventiva
ATM Program Common Stock
Sole Sales Agent
Read more
about Esperion Therapeutics, Inc. - 2025/10/07
$75.0 Million
Image
Esperion Therapeutics
Confidentially Marketed Follow-On Offering
Lead Bookrunner
Pagination
Page 1
Next page
››
Subscribe to Biopharma